186. Seed Investing at the Intersection of Biology & Technology (Jenny Rooke)
This post is by Nick Moran from The Full Ratchet: VC | Venture Capital | Angel Investors | Startup Investing | Fundraising | Crowdfunding | Pitch | Private Equity | Business Loans
Jenny Rooke of Genoa Ventures joins Nick to discuss Seed Investing at the Intersection of Biology & Technology. In this episode, we cover:
- Her background in genetics, physics, computer science... and how that lead to venture.
- How was it to work with Melinda and Bill Gates?
- You also successfully built the largest life-sciences syndicate on Angellist that is also one of the highest performing syndicates of any sector... I just took a peek at the rankings this morning and both New Stack and Genoa are in the top 5. Of course those rankings are done based on follow-on rate... so, it's nice to see we are in good company, up there w/ you Jenny... but talk a bit about why you started with a syndicate and how you've been able to drive such high performance.
- You launched the Genoa fund last year... Syndicate and fund now?
- "Genoa ventures invests in early-stage companies innovating at the intersection of biology and technology"... Jenny, what does that mean to you and what types of companies are you looking for?
- Adverse effects from Theranos?
- How and where do you source dealflow?
- Talk a bit about your evaluation process and some of the unique things that you do when vetting prospective portfolio companies?
- What's your take on VCs that pick a focus area and stay distinctly in their lane vs. those VCs that may have a focus but tend to dabble in variety of other areas?
- A position I've heard from many tech VCs is... (Read more...)